Clinical data from Indaptus’ ongoing Phase 1 trial evaluating Decoy20 in advanced solid tumors.
RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...
Learn more about whether Amicus Therapeutics, Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether PTC Therapeutics, Inc. or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter.
Paperplane Therapeutics has raised $1.5 million to treat patients for pain and anxiety using virtual reality, possibly making trips to the dentist more pleasant. The Montreal, Canada-based company ...
Nurix Therapeutics, Inc. stock slid 40% after promising NX-5948 results in CLL. NX-5948 shows efficacy in heavily pre-treated ...
10d
Hosted on MSNStatement By H.E. Mia a. Mottley, Prime Minister of Barbados, At the 38th AU Summit [document]Your Excellencies, may I start by acknowledging the Chairperson of the African Union, the President of Angola; Your Excellency, the Prime Minister of the Federal Democratic Republic of Ethiopia and ...
Augustine Therapeutics appoints Gerhard Koenigas Chief Executive Officer as Company Prepares to Enter the ClinicIndustry veteran Gerhard Koenig, ...
When it comes to the price of a subscription, Amazon Prime gives members multiple options to choose from. Amazon offers a discounted version of its subscription service for college students which ...
Aaron covers what's exciting and new in the world of home entertainment and streaming TV. Previously, he wrote about entertainment for places like Rotten Tomatoes, Inverse, TheWrap and The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results